CCL24

CCL24 Overview

English NameChemokine (C-C Motif) Ligand 24Approved Drugs0
Drugs in Clinical Trials1Target SynonymSmall Inducible Cytokine Subfamily A (Cys-Cys), Member 24,Chemokine (C-C Motif) Ligand 24,Small-Inducible Cytokine A24,MPIF-2,Ckb-6,Chemokine CCL24,MPIF2,SCYA24,Eotaxin-2,CK-beta-6,Myeloid progenitor inhibitory factor 2,C-C motif chemokine 24,CCL24,C-C Motif Chemokine Ligand 24,Eosinophil Chemotactic Protein 2
Highest Development StagePhase 2 Clinical
English NameChemokine (C-C Motif) Ligand 24
Target SynonymSmall Inducible Cytokine Subfamily A (Cys-Cys), Member 24,Chemokine (C-C Motif) Ligand 24,Small-Inducible Cytokine A24,MPIF-2,Ckb-6,Chemokine CCL24,MPIF2,SCYA24,Eotaxin-2,CK-beta-6,Myeloid progenitor inhibitory factor 2,C-C motif chemokine 24,CCL24,C-C Motif Chemokine Ligand 24,Eosinophil Chemotactic Protein 2
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 2 Clinical

CCL24 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
CC4-H52H1
Human
HEK293
Human CCL24/Eotaxin-2 Protein, His Tag (HPLC verified)
Total: 1
  • 1

CCL24 Background

C-C motif chemokine ligand 24 (CCL24), also known as eotaxin2, belongs to CC chemokines like MCP-1, and it mainly chemoattracts eosinophils. CCL24 can promote the separation of eosinophils from endothelial cells and then combine with its sole ligand to promote eosinophils to enter the tissue. CCL24 was not originally found in eosinophils but was first isolated from monocytes. Latest, it was found that the expression of CCL24 in the bronchial epithelial cells of asthma patients increased. CCL24 promotes immune cell trafficking and activation as well as profibrotic activities through the CCR3 receptor (C-C chemokine receptor type 3). Both CCL24 and CCR3 is involved in lung and skin inflammation and fibrosis.

CCL24 Synonyms

C-C motif chemokine 24,CK-beta-6,Eosinophil chemotactic protein 2,Myeloid progenitor inhibitory factor 2,Small-inducible cytokine A24,Eotaxin-2,MPIF-2,SCYA24,MPIF2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
NebokitugCM-101Phase 2 ClinicalChemomab Therapeutics LtdCholangitis, Sclerosing; Metabolic Dysfunction-Associated Steatotic Liver Disease; Scleroderma, Systemic
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8